Monoclonal Antibodies And Immunotoxins Reactive With Epidermal Growth Factor Receptor And Epidermal Growth Factor Receptor Variant III
US Application 61/044,190
Filed on 2008-04-11
Filed on 2008-04-11
N4 Modification Of Nucleotides For Increased Stability, Oral Boavailability, Targeted Delivery And Combination Therapy
US Application 60/943,172
Filed on 2007-06-11
Filed on 2007-06-11
IMMUNOTOXINS MADE WITH MODIFIED CHOLIX TOXIN AND USES THEREOF
US Application 61/058,872
Filed on 2008-06-04
Filed on 2008-06-04
Optimization Of Expression Of Multimeric Proteins
US Application 61/052,916
Filed on 2008-05-13
Filed on 2008-05-13
OPTIMIZATION OF EXPRESSION OF HETERODIMERS
US Application 61/052,239
Filed on 2008-05-11
Filed on 2008-05-11
Use Of Lasonolide A To Induce Premature Chromosome Condensation And As A Novel Anti-cancer Agent
US Application 61/137,193
Filed on 2008-07-28
Filed on 2008-07-28
HMGN POLYPEPTIDES AS IMMUNE ENHANCERS AND HMGN ANTAGONISTS AS IMMUNE SUPPRESSANTS
US Application 61/083,781
Filed on 2008-07-25
Filed on 2008-07-25
METHOD OF TREATING PNEUMOCONIOSIS WITH OLIGODEOXYNUCLEOTIDES
US Application 61/055,102
Filed on 2008-05-21
Filed on 2008-05-21
COMPOSITIONS AND METHODS USEFUL FOR DETECTING AND TREATING DISEASES ASSOCIATED WITH 16P CHROMOSOMAL DISRUPTIONS
US Application 61/121,997
Filed on 2008-12-12
Filed on 2008-12-12